Centre Hospitalier Régional de Quebec, Université Laval

Who: Stage IIIC or IV epithelial ovarian, fallopian or peritoneal cancer (biopsy proven: no more surgery)
What: Study comparing upfront debulking vs neo-adjuvant chemotherapy in patients with stage IIIC or IV epithelial ovarian cancer

Contact: Dr. Marie Plante

A phase III study of cisplatin plus topotecan followed by paciltaxel plus carboplatin versus paclitaxel plus carboplatin as first line chemotherapy in women with newly diagnosed advanced epithelial ovarian cancer

Contact: Dr. Marie Plante

Phase II Study of CCI-779 in Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

Contact: Dr. Marie Plante

A phase III randomized clinical trial of laparoscopic pelvic and para-aortic node sampling with vaginal hysterectomy and BSO versus open laparotomy with pelvic and para-aortic node sampling and abdominal hysterectomy and BSO in endometrial adenocarcinoma and uterine sarcoma, clinical stage I, IIA, Grade I,II, III.

Contact: Dr. Marie Plante

Phase III Study of Intraoperative Lymphatic Mapping in Patients With Invasive Squamous Cell Carcinoma of the Vulva

Contact: Dr. Marie Plante

Phase III Randomized Study of Paclitaxel and Cisplatin Versus Vinorelbine and Cisplatin Versus Gemcitabine and Cisplatin Versus Topotecan and Cisplatin in Patients With Stage IVB, Recurrent, or Persistent Carcinoma of the Cervix

Contact: Dr. Marie Plante

Phase III Randomized Study of Doxorubicin, Cisplatin, Paclitaxel, and Filgrastim (G-CSF) Versus Carboplatin and Paclitaxel in Patients With Stage III or IV or Recurrent Endometrial Cancer

Contact: Dr. Marie Plante

Caelyx/carbo in recurrent ovarian cancer

Contact: Dr. Marie Plante

Cisplatin/topotecan in advanced/recurrent cervical cancer (about to close)

Contact: Dr. Marie Plante

Pfizer

(on hold)

VEGF in ovarian cancer (ON HOLD-INTERIM ANALYSIS)

Contact: Dr. Marie Plante